Heron Therapeutics Inc (HRTX)
2.65
-0.15
(-5.36%)
USD |
NASDAQ |
Apr 24, 16:00
2.67
+0.02
(+0.75%)
After-Hours: 20:00
Heron Therapeutics Shareholders Equity (Quarterly): -33.97M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -33.97M |
September 30, 2023 | -27.79M |
June 30, 2023 | -39.28M |
March 31, 2023 | -11.43M |
December 31, 2022 | 13.57M |
September 30, 2022 | 22.45M |
June 30, 2022 | -21.74M |
March 31, 2022 | 23.96M |
December 31, 2021 | 77.57M |
September 30, 2021 | 118.84M |
June 30, 2021 | 160.11M |
March 31, 2021 | 196.22M |
December 31, 2020 | 236.49M |
September 30, 2020 | 277.15M |
June 30, 2020 | 324.06M |
March 31, 2020 | 365.47M |
December 31, 2019 | 403.84M |
September 30, 2019 | 285.44M |
June 30, 2019 | 305.36M |
March 31, 2019 | 331.81M |
December 31, 2018 | 370.16M |
September 30, 2018 | 406.81M |
June 30, 2018 | 431.89M |
March 31, 2018 | 92.21M |
December 31, 2017 | 131.14M |
Date | Value |
---|---|
September 30, 2017 | 40.05M |
June 30, 2017 | 69.08M |
March 31, 2017 | 102.16M |
December 31, 2016 | -21.25M |
September 30, 2016 | 17.88M |
June 30, 2016 | 57.84M |
March 31, 2016 | 92.68M |
December 31, 2015 | 118.11M |
September 30, 2015 | 141.70M |
June 30, 2015 | 159.87M |
March 31, 2015 | 48.00M |
December 31, 2014 | 63.06M |
September 30, 2014 | 81.01M |
June 30, 2014 | 97.85M |
March 31, 2014 | 55.41M |
December 31, 2013 | 68.94M |
September 30, 2013 | 20.87M |
June 30, 2013 | 28.50M |
March 31, 2013 | 41.38M |
December 31, 2012 | 51.82M |
September 30, 2012 | 57.52M |
June 30, 2012 | 11.12M |
March 31, 2012 | 11.63M |
December 31, 2011 | 15.75M |
September 30, 2011 | 19.19M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-39.28M
Minimum
Jun 2023
403.84M
Maximum
Dec 2019
140.86M
Average
118.84M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
United Therapeutics Corp | 5.985B |
Esperion Therapeutics Inc | -454.99M |
Aldeyra Therapeutics Inc | 119.80M |
Ocular Therapeutix Inc | 91.13M |
Clearside Biomedical Inc | -15.91M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 222.51M |
Total Liabilities (Quarterly) | 256.48M |
Debt to Equity Ratio | -5.114 |
Current Ratio | 2.369 |
Net Debt Paydown Yield | -1.92% |